ResearcherUniversity Hospital BonnActive in the last 2 years
Maria Angeles Gonzalez-Carmona
Matched on ORCID iD 0000-0003-3956-1457; OpenAlex author ID A5033769350. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers
Papers 6
- US-guided high-intensity focused ultrasound in pancreatic cancer treatment: a consensus initiative between Chinese and European HIFU centers. Co-author DOI 10.1080/02656736.2023.2295812↗
- Study Protocol of a Randomized, Two-Arm, Phase I/II Trial Investigating the Feasibility, Safety, and Efficacy of Local Treatment with US-Guided High-Intensity … Last author DOI 10.3390/jcm13133717↗
- Second-line and third-line therapy with nanoliposomal irinotecan (nal-IRI) in pancreatic cancer: a single-center experience and review of literature. Last author DOI 10.21037/jgo-22-632↗
- A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Downstream Mediators in Pancreatic Cancer Ce… Co-author DOI 10.3390/ijms23073783↗
- Improving quality of life in pancreatic cancer patients following high-intensity focused ultrasound (HIFU) in two European centers. Co-author DOI 10.1007/s00330-020-07682-z↗
- FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.13730↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Milka Marinova · 4 shared papers, 2021–2024 · strength 0.63
- Paper US-guided high-intensity focused ultrasound in pancreatic cancer treatment: a consensus initiative between Chinese and … DOI 10.1080/02656736.2023.2295812↗
- Paper Second-line and third-line therapy with nanoliposomal irinotecan (nal-IRI) in pancreatic cancer: a single-center experi… DOI 10.21037/jgo-22-632↗
- Paper Study Protocol of a Randomized, Two-Arm, Phase I/II Trial Investigating the Feasibility, Safety, and Efficacy of Local … DOI 10.3390/jcm13133717↗
- Holger M. Strunk · 3 shared papers, 2021–2024 · strength 0.47
- Paper US-guided high-intensity focused ultrasound in pancreatic cancer treatment: a consensus initiative between Chinese and … DOI 10.1080/02656736.2023.2295812↗
- Paper Study Protocol of a Randomized, Two-Arm, Phase I/II Trial Investigating the Feasibility, Safety, and Efficacy of Local … DOI 10.3390/jcm13133717↗
- Paper Improving quality of life in pancreatic cancer patients following high-intensity focused ultrasound (HIFU) in two Europ… DOI 10.1007/s00330-020-07682-z↗
- Ingo G.H. Schmidt‐Wolf · 3 shared papers, 2019–2024 · strength 0.44
- Paper A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Down… DOI 10.3390/ijms23073783↗
- Paper Study Protocol of a Randomized, Two-Arm, Phase I/II Trial Investigating the Feasibility, Safety, and Efficacy of Local … DOI 10.3390/jcm13133717↗
- Paper FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer Ce… DOI 10.21873/anticanres.13730↗
- Dobromir Dimitrov Dimitrov · 2 shared papers, 2021–2024 · strength 0.32
- Paper US-guided high-intensity focused ultrasound in pancreatic cancer treatment: a consensus initiative between Chinese and … DOI 10.1080/02656736.2023.2295812↗
- Paper Improving quality of life in pancreatic cancer patients following high-intensity focused ultrasound (HIFU) in two Europ… DOI 10.1007/s00330-020-07682-z↗
- Tim R. Glowka · 2 shared papers, 2023–2024 · strength 0.32
- Paper Second-line and third-line therapy with nanoliposomal irinotecan (nal-IRI) in pancreatic cancer: a single-center experi… DOI 10.21037/jgo-22-632↗
- Paper Study Protocol of a Randomized, Two-Arm, Phase I/II Trial Investigating the Feasibility, Safety, and Efficacy of Local … DOI 10.3390/jcm13133717↗
- Christian Möhring · 2 shared papers, 2023–2024 · strength 0.32
- Paper Second-line and third-line therapy with nanoliposomal irinotecan (nal-IRI) in pancreatic cancer: a single-center experi… DOI 10.21037/jgo-22-632↗
- Paper Study Protocol of a Randomized, Two-Arm, Phase I/II Trial Investigating the Feasibility, Safety, and Efficacy of Local … DOI 10.3390/jcm13133717↗
- Georg Feldmann · 2 shared papers, 2023–2024 · strength 0.32
- Paper Second-line and third-line therapy with nanoliposomal irinotecan (nal-IRI) in pancreatic cancer: a single-center experi… DOI 10.21037/jgo-22-632↗
- Paper Study Protocol of a Randomized, Two-Arm, Phase I/II Trial Investigating the Feasibility, Safety, and Efficacy of Local … DOI 10.3390/jcm13133717↗
- Francesca Garofano · 2 shared papers, 2019–2022 · strength 0.29
- Paper A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Down… DOI 10.3390/ijms23073783↗
- Paper FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer Ce… DOI 10.21873/anticanres.13730↗
- Marcus O. Thudium · 2 shared papers, 2021–2024 · strength 0.26
- Paper Study Protocol of a Randomized, Two-Arm, Phase I/II Trial Investigating the Feasibility, Safety, and Efficacy of Local … DOI 10.3390/jcm13133717↗
- Paper Improving quality of life in pancreatic cancer patients following high-intensity focused ultrasound (HIFU) in two Europ… DOI 10.1007/s00330-020-07682-z↗
- Joan Vidal-Jové · 1 shared paper, 2024 · strength 0.21
- Kun Zhou · 1 shared paper, 2024 · strength 0.21
- Maria F. Setiawan · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.